SFS
NBIX icon

Sowell Financial Services’s Neurocrine Biosciences NBIX Stock Holding History

Sowell Financial Services’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
6,054
+872
+17% +$129K 0.03% 459
2026
Q1 		$683K Buy
5,182
+326
+7% +$43.3K 0.03% 540
2025
Q4 		$689K Sell
4,856
-49
-1% -$7.1K 0.03% 547
2025
Q3 		$689K Buy
4,905
+12
+0.2% +$1.63K 0.03% 540
2025
Q2 		$615K Buy
4,893
+107
+2% +$12.3K 0.03% 554
2025
Q1 		$529K Buy
+4,786
New +$606K 0.02% 569
2024
Q3 		– Sell
-10,914
Closed -$1.5M – 569
2024
Q2 		$1.5M Sell
10,914
-2
-0% -$274 0.07% 271
2024
Q1 		$1.51M Buy
+10,916
New +$1.49M 0.07% 279
2021
Q2 		– Sell
-1,554
Closed -$139K – 1930
2021
Q1 		$139K Sell
1,554
-99
-6% -$10.4K ﹤0.01% 1225
2020
Q4 		$158K Buy
1,653
+182
+12% +$17.6K 0.01% 950
2020
Q3 		$141K Sell
1,471
-419
-22% -$48.5K 0.01% 857
2020
Q2 		$231K Buy
1,890
+1,014
+116% +$112K 0.01% 670
2020
Q1 		$76K Buy
876
+63
+8% +$6.17K 0.01% 921
2019
Q4 		$87K Buy
813
+659
+428% +$69K 0.01% 962
2019
Q3 		$14K Buy
+154
New +$14.4K ﹤0.01% 1415

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Sowell Financial Services's NBIX Position: Q2 2026 in Review

Sowell Financial Services increased its Neurocrine Biosciences (NBIX) stake by 17% in Q2 2026, buying an estimated $129K and bringing the position to 6,054 shares worth $1.02M. The position accounts for 0.03% of the portfolio, ranked #459.

Sowell Financial Services first reported a position in NBIX in Q3 2019 and has held it in 15 quarters since. The position peaked at $1.51M in Q1 2024. 772 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Sowell Financial Services held 6,054 shares of Neurocrine Biosciences worth $1.02M as of Q2 2026.
  • Sowell Financial Services bought 872 Neurocrine Biosciences shares in Q2 2026, an estimated $129K.
  • Neurocrine Biosciences made up 0.03% of Sowell Financial Services's portfolio in Q2 2026, its #459 holding.
  • Sowell Financial Services first reported a position in Neurocrine Biosciences in Q3 2019 and has held it in 15 quarters since.
  • Sowell Financial Services's Neurocrine Biosciences position peaked at $1.51M in Q1 2024.
  • 772 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Sowell Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.